William Blair Investment Management LLC acquired a new position in shares of Cencora, Inc. (NYSE:COR – Free Report) in the 2nd quarter, Holdings Channel reports. The institutional investor acquired 2,775 shares of the company’s stock, valued at approximately $785,000.
A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. ExodusPoint Capital Management LP acquired a new position in Cencora during the 4th quarter worth about $16,487,000. Impact Partnership Wealth LLC acquired a new stake in Cencora in the 1st quarter valued at about $1,170,000. SEB Asset Management AB bought a new position in shares of Cencora in the first quarter worth about $134,139,000. PFA Pension Forsikringsaktieselskab acquired a new position in shares of Cencora during the fourth quarter worth approximately $59,145,000. Finally, Summit Global Investments acquired a new position in shares of Cencora during the second quarter worth approximately $2,283,000. 97.52% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of analysts recently weighed in on COR shares. William Blair assumed coverage on shares of Cencora in a report on Tuesday, April 28th. They issued a “market perform” rating for the company. Royal Bank Of Canada started coverage on Cencora in a report on Wednesday. They set a “sector perform” rating and a $330.00 price objective on the stock. Wells Fargo & Company increased their price objective on Cencora from $331.00 to $395.00 and gave the company an “overweight” rating in a research report on Tuesday, August 11th. Wall Street Zen raised Cencora from a “hold” rating to a “buy” rating in a research note on Saturday, August 8th. Finally, Bank of America boosted their target price on Cencora from $280.00 to $285.00 and gave the stock a “neutral” rating in a research report on Wednesday, June 24th. Thirteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $370.85.
Cencora Trading Down 0.0%
COR opened at $317.89 on Monday. The firm has a 50 day simple moving average of $302.59 and a 200 day simple moving average of $311.52. Cencora, Inc. has a fifty-two week low of $244.82 and a fifty-two week high of $377.54. The company has a market cap of $60.66 billion, a price-to-earnings ratio of 23.62, a price-to-earnings-growth ratio of 1.83 and a beta of 0.57. The company has a debt-to-equity ratio of 3.53, a current ratio of 0.93 and a quick ratio of 0.58.
Cencora (NYSE:COR – Get Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $4.48 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.35 by $0.13. Cencora had a net margin of 0.79% and a return on equity of 125.45%. The firm had revenue of $84.75 billion for the quarter, compared to analysts’ expectations of $84.31 billion. During the same period last year, the firm earned $4.00 earnings per share. The business’s revenue for the quarter was up 5.1% on a year-over-year basis. On average, sell-side analysts anticipate that Cencora, Inc. will post 17.87 earnings per share for the current year.
Cencora Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Monday, August 31st. Stockholders of record on Friday, August 14th will be given a $0.60 dividend. This represents a $2.40 annualized dividend and a dividend yield of 0.8%. The ex-dividend date is Friday, August 14th. Cencora’s dividend payout ratio (DPR) is currently 17.83%.
Cencora declared that its board has initiated a stock buyback program on Thursday, May 21st that authorizes the company to buyback $2.00 billion in shares. This buyback authorization authorizes the company to purchase up to 3.9% of its stock through open market purchases. Stock buyback programs are generally a sign that the company’s management believes its shares are undervalued.
Insider Activity
In related news, Director Lauren M. Tyler acquired 550 shares of the firm’s stock in a transaction that occurred on Monday, June 22nd. The stock was acquired at an average cost of $270.23 per share, with a total value of $148,626.50. Following the completion of the purchase, the director directly owned 4,359 shares in the company, valued at approximately $1,177,932.57. This trade represents a 14.44% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.38% of the stock is owned by corporate insiders.
About Cencora
Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.
Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.
See Also
- Five stocks we like better than Cencora
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Want to see what other hedge funds are holding COR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cencora, Inc. (NYSE:COR – Free Report).
Receive News & Ratings for Cencora Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cencora and related companies with MarketBeat.com's FREE daily email newsletter.
